ID

12471

Beschreibung

The purpose of the study is to assess the efficacy (prevention of vascular events) and safety (especially bleedings) of Ticagrelor (AZD6140) compared with Clopidogrel, both given on top of low dose aspirin, in Asian/Japanese patients with acute coronary syndrome and a planned percutaneous coronary intervention (PCI). https://clinicaltrials.gov/ct2/show/NCT01294462

Link

https://clinicaltrials.gov/ct2/show/NCT01294462

Stichworte

  1. 28.07.15 28.07.15 -
  2. 21.11.15 21.11.15 -
Hochgeladen am

21. November 2015

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Ticagrelor Versus Clopidogrel Acute Coronary Syndrome NCT01294462

Eligibility criteria

  1. StudyEvent: ODM
    1. Eligibility criteria
Inclusion Criteria
Beschreibung

Inclusion Criteria

Provision of signed informed consent
Beschreibung

Provision of signed informed consent

Datentyp

boolean

Alias
UMLS CUI-1
C0021430
Index event of ST segment elevation ACS
Beschreibung

Index event of non-ST or ST segment elevation ACS

Datentyp

boolean

Alias
UMLS CUI-1
C1536220
Index event of non-ST segment elevation ACS
Beschreibung

Index event of non-ST segment elevation ACS

Datentyp

boolean

Alias
UMLS CUI-1
C3537184
Exclusion criteria
Beschreibung

Exclusion criteria

Index event is an acute complication of percutaneous coronary intervention
Beschreibung

Index event is an acute complication of percutaneous coronary intervention

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0009566
UMLS CUI [1,2]
C1532338
Patient has undergone Percutaneous Coronary Intervention (PCI) after the index event before the first dose of study treatment
Beschreibung

Patient has undergone Percutaneous Coronary Intervention (PCI) after the index event before the first dose of study treatment

Datentyp

boolean

Alias
UMLS CUI-1
C1532338
Oral anticoagulation therapy that cannot be stopped
Beschreibung

Oral anticoagulation therapy that cannot be stopped

Datentyp

boolean

Alias
UMLS CUI-1
C0003281
The conditions associated with increased risk of bradycardiac events
Beschreibung

The conditions associated with increased risk of bradycardiac events

Datentyp

boolean

Alias
UMLS CUI-1
C0428977

Ähnliche Modelle

Eligibility criteria

  1. StudyEvent: ODM
    1. Eligibility criteria
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
Inclusion Criteria
Informed consent
Item
Provision of signed informed consent
boolean
C0021430 (UMLS CUI-1)
STEMI
Item
Index event of ST segment elevation ACS
boolean
C1536220 (UMLS CUI-1)
NSTEMI
Item
Index event of non-ST segment elevation ACS
boolean
C3537184 (UMLS CUI-1)
Item Group
Exclusion criteria
PCI complication
Item
Index event is an acute complication of percutaneous coronary intervention
boolean
C0009566 (UMLS CUI [1,1])
C1532338 (UMLS CUI [1,2])
PCI
Item
Patient has undergone Percutaneous Coronary Intervention (PCI) after the index event before the first dose of study treatment
boolean
C1532338 (UMLS CUI-1)
anticoagulation therapy
Item
Oral anticoagulation therapy that cannot be stopped
boolean
C0003281 (UMLS CUI-1)
Bradycardia
Item
The conditions associated with increased risk of bradycardiac events
boolean
C0428977 (UMLS CUI-1)

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video